Rho Immune Globulin and Rh Incompatibility

1874 Words4 Pages

Rho (D) immune globulin, better known by its brand name Rhogam, is made from human blood and provided in a sterile solution. Rhogam is used most commonly to prevent an immune response to Rh positive blood in individuals that have an Rh negative blood type. In addition to the above use, Rhogam is also used to treat immune thrombocytopenic purpura or ITP. Rhogam is a relatively new drug and its beginnings can be traced back to one donor in Australia.

Development of Rho (D) Immune Globulin

Firstly, it is important to discuss the beginnings of this drug as it has an amazing story that goes with it. In 1950, an Australian teenager was admitted to a hospital needing to have major thoracic surgery. As a result of this surgery the teenager, James Harrison, required 13 liters of blood. As he lay in a hospital bed for three months Mr. Harrison realized that the donors of the blood that he needed, saved his life and swore to his father that he would start donating blood himself as soon as he could do so legally at the age of 18. In 1954 James Harrison, staying true to his word, started giving his donations of blood. Within just a few donations however, it was realized that his blood contained an extremely rare antibody called Rho (D) immune globulin. Almost immediately Mr. Harrison started helping in the experimentation and development of a vaccine that would be later become known by various trade names such as Sky Med, Rhogam, Rhesonativ, Micrhogam, and Rhesugam and others. The first injection of Rho (D) immune globulin was given in 1968. The donations of Mr. James Harrison are attributed in saving the lives of over 2 million newborns, and the research was so important that in the 1950’s, his life was insured for 1 million doll...

... middle of paper ...

...ermined to be mature enough to go ahead with delivery. Babies that are born with erythroblastosis are closely monitored in the case that they may need exchange transfusion (Dulay, 2014).

Great care should be taken in assessing the possibility of Rh incompatibility. This is an easily prevented condition to address before it becomes a problem for the baby when it is exposed to Rh-positive antibodies that can destroy the red blood cells (PubMed Staff, 2013). When the red blood cells are attacked as foreign, the baby can experience a range of health issues that can range from jaundice to brain damage, and even death (Dulay, 2014). An Rh-negative female should be tested and receive the Rho(D) immune globulin injection to ensure protection against the production of anti-Rh0(D) antibodies as a conservative measure to ensure that Rh disease is not of concern.

More about Rho Immune Globulin and Rh Incompatibility

Open Document